The proportion of U.S. abortions administered by medication rose to more than 60% in 2023 following a decline in surgical abortion access after the U.S. Supreme Court overturned Roe v. Wade. Access to medication abortion is now crucial as restrictions on abortion rights increase.
Key Points
Proportion of U.S. abortions administered by medication rose to over 60% in 2023
Access to medication abortion crucial as surgical abortion access declines
Oral arguments scheduled in U.S. Supreme Court regarding broad access to mifepristone
Pros
Increased access to medication abortion as an alternative to surgical procedures
Greater awareness and acceptance of medication abortion as a safe and effective method
Cons
Restrictions on abortion rights leading to limited access to surgical abortion procedures
Uncertainty regarding the future of broad access to medication abortion